SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001618835-20-000203
Filing Date
2020-06-18
Accepted
2020-06-18 16:29:37
Documents
1
Period of Report
2020-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_159251215883461.html 4/A  
1 FORM 4/A wf-form4a_159251215883461.xml 4/A 3912
  Complete submission text file 0001618835-20-000203.txt   5443
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Issuer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EVOFEM BIOSCIENCES, INC. 12400 HIGH BLUFF DIRVE, SUITE 600 SAN DIEGO CA 92130
Business Address
Hall William Walmsley (Reporting) CIK: 0001726731 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36754 | Film No.: 20972936